A bridge between evidence-based laboratory diagnostics and research in neuroimmunology: why standardizations and guidelines matter

Neurol Sci. 2017 Oct;38(Suppl 2):213-216. doi: 10.1007/s10072-017-3022-6.
No abstract available

Keywords: Anti-myelin oligodendrocyte glycoprotein antibodies; Autoantibodies; National healthcare system; Neurological autoimmune diseases; Statistics.

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Autoantibodies / metabolism*
  • Biomarkers / metabolism
  • Biomedical Research / standards*
  • Biomedical Research / statistics & numerical data
  • Clinical Laboratory Techniques / standards*
  • Clinical Laboratory Techniques / statistics & numerical data
  • Data Interpretation, Statistical
  • Evidence-Based Medicine / standards*
  • Evidence-Based Medicine / statistics & numerical data
  • Humans
  • Immune System Diseases / diagnosis*
  • Immune System Diseases / metabolism
  • Myelin-Oligodendrocyte Glycoprotein / immunology
  • Nervous System Diseases / diagnosis*
  • Nervous System Diseases / immunology
  • Practice Guidelines as Topic / standards
  • Quality Control

Substances

  • Autoantibodies
  • Biomarkers
  • Myelin-Oligodendrocyte Glycoprotein